The purpose of this study is to use Randomized Controlled Trial (RCT) methods to examine the influence of novel tobacco products on biomarkers of toxicant exposure and disease risk, reports of adverse events, and concurrent use of other tobacco products. In this case, the novel products are one type of electronic cigarette and an imitation cigarette or cigarette substitute.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
520
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Center for the Study of Tobacco Products
Richmond, Virginia, United States
urine carcinogen biomarker of exposure, NNAL
changes in NNAL concentration measured at week 0, week 4, week 12, and week 24
Time frame: week 24
urine biomarker of nicotine exposure, cotinine
changes in cotinine concentration measured at week 0, week 4, week 12, and week 24
Time frame: week 24
blood, urine, and exhaled breath condensate biomarkers of oxidative stress, glutathione and 8 Isoprostanes
changes in oxidative stress biomarker concentrations measured at week 0, week 4, week 12, and week 24
Time frame: week 24
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.